BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Korokin M, Gureev V, Gudyrev O, Golubev I, Korokina L, Peresypkina A, Pokrovskaia T, Lazareva G, Soldatov V, Zatolokina M, Pobeda A, Avdeeva E, Beskhmelnitsyna E, Denisyuk T, Avdeeva N, Bushueva O, Pokrovskii M. Erythropoietin Mimetic Peptide (pHBSP) Corrects Endothelial Dysfunction in a Rat Model of Preeclampsia. Int J Mol Sci 2020;21:E6759. [PMID: 32942669 DOI: 10.3390/ijms21186759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Martínez-Villaluenga C, Hernández-Ledesma B. Peptides for Health Benefits 2020. Int J Mol Sci 2022;23:6699. [PMID: 35743143 DOI: 10.3390/ijms23126699] [Reference Citation Analysis]
2 Antsiferov OV, Cherevatenko RF, Korokin MV, Gureev VV, Gureeva AV, Zatolokina MA, Avdeyeva EV, Zhilinkova LA, Kolesnik IM. A new EPOR/CD131 heteroreceptor agonist EP-11-1: a neuroprotective effect in experimental traumatic brain injury. RRP 2021;7:1-9. [DOI: 10.3897/rrpharmacology.7.75301] [Reference Citation Analysis]
3 Antsiferova OE, Teleshchenko MP, Tsuverkalova YM, Pokrovsky MV, Gureev VV, Zatolokina MA, Gureeva AV. CORRECTION OF MORPHOFUNCTIONAL DISORDERS IN EXPERIMENTAL PREECLAMPSY BY COMBINED USE OF TRIMETAZIDINE AND PURIFIED MICRONIZED FLAVONOID FRACTION AS WELL AS THEIR COMBINATIONS WITH METHYLAMPSY. Farm farmakol (Pâtigorsk) 2021;8:304-315. [DOI: 10.19163/2307-9266-2020-8-5-304-315] [Reference Citation Analysis]
4 Puchenkova OA, Nadezhdin SV, Soldatov VO, Zhuchenko MA, Korshunova DS, Kubekina MV, Korshunov EN, Korokina LV, Golubinskaya PA, Kulikov AL, Gureev VV, Pokrovskiy VM, Patrakhanov EA, Lebedev PR, Denisyuk TA, Belyaeva VS, Movchan EA, Lepetukha EI, Pokrovskiy MV. STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR. Farm farmakol (Pâtigorsk) 2020;8:100-11. [DOI: 10.19163/2307-9266-2020-8-2-100-111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
5 Belyaeva VS, Stepenko YV, Lyubimov II, Kulikov AL, Tietze AA, Kochkarova IS, Martynova OV, Pokopeyko ON, Krupen’kina LA, Nagikh AS, Pokrovskiy VM, Patrakhanov EA, Belashova AV, Lebedev PR, Gureeva AV. Non-hematopoietic erythropoietin-derived peptides for atheroprotection and treatment of cardiovascular diseases. RRP 2020;6:75-86. [DOI: 10.3897/rrpharmacology.6.58891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Korokin M, Pokrovsky M, Korokina L, Soldatov V, Antsiferov O, Vasyutkin V, Gureev V. Peptides mimicking the spatial structure of erythropoietin α-chain B — new possibilities for the treatment and prevention of hyperhomocysteine-induced endothelial dysfunction. Profil med 2020;23:105. [DOI: 10.17116/profmed202023062105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]